Tissue engineered models for in vitro studies

Fundamentals of Tissue Engineering and Regenerative Medicine

Volumn , Issue , 2009, Pages 759-772

  McLaughlin, Cristopher R ^a   Osborne, Rosemarie ^b   Hyatt, A ^a   Watsky, Mitchell A ^c   Dare, Emma V ^d   Jarrold, Bradley B ^b   Mullins, Lisa A ^b   Griffith, May ^a  

^a UNIVERSITY OF OTTAWA EYE INSTITUTE   (Canada)

^b PROCTER AND GAMBLE COMPANY   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70350115657     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-77755-7_52     Document Type: Chapter

References (132)

1. Vacanti JP, Langer R (1999) Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation. Lancet 354 Suppl 1:SI32-4
2. Atala A, Lanza RP, editors (2002) Methods of Tissue Engineering. San Diego: Academic Press;
3. Boudreau N, Myers C, Bissell MJ (1995) From laminin to lamin: regulation of tissue-specifc gene expression by the ECM. Trends Cell Biol 5:1-4
4. Baldwin HS (1996) Early embryonic vascular development. Cardiovasc Res 31 Spec No:E34-45
5. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, et al. (1998) Extension of life-span by introduction of telomerase into normal human cells. Science 279:349-52
6. Jiang XR, Jimenez G, Chang E, Frolkis M, Kusler B, Sage M, et al. (1999) Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat Genet 21:111-4
7. Huschtscha LI, Reddel RR (1999) p16(INK4a) and the control of cellular proliferative life span. Carcinogenesis 20:921-6
8. Wynford-Thomas D (1996) p53: guardian of cellular senescence. J Pathol 180:118-21
9. Rhim JS, Tsai WP, Chen ZQ, Chen Z, Van Waes C, Burger AM, et al. (1998) A human vascular endothelial cell model to study angiogenesis and tumorigenesis. Car-cinogenesis 19:673-81
10. Watsky MA, Griffth M (2000) Whose Naughty or Nice: Electrophysiological Screening of Cells for Use in Tissue-Engineered Corneas. e-biomed: The Journal of Regenerative Medicine 1:115-20
11. Rae J, Cooper K, Gates P, Watsky M (1991) Low access resistance perforated patch recordings using amphoteri-cin B. J Neurosci Methods 37:15-26
12. Nishida T. Cornea (1997) Fundamentals of cornea and external disease. In: Krachmer JJ, Mannis MJ, Holland EJ, editors. Cornea. St. Louis, Missouri: Mosby-Year Book Inc. p. 3-27
13. Jonas JB, Holbach L (2005) Central corneal thickness and thickness of the lamina cribrosa in human eyes. Invest Ophthalmol Vis Sci 46:1275-9
14. Freegard TJ (1997) The physical basis of transparency of the normal cornea. Eye 11 (Pt 4):465-71
15. Niederkorn JY (1990) Immune privilege and immune regulation in the eye. Adv Immunol 48:191-226
16. Rozsa AJ, Beuerman RW (1982) Density and organization of free nerve endings in the corneal epithelium of the rabbit. Pain 14:105-20
17. Ren H, Wilson G (1996) Apoptosis in the corneal epithelium. Invest Ophthalmol Vis Sci 37:1017-25
18. Dua HS, Azuara-Blanco A (2000) Limbal stem cells of the corneal epithelium. Surv Ophthalmol 44:415-25
19. Sack RA, Nunes I, Beaton A, Morris C (2001) Host-defense mechanism of the ocular surfaces. Biosci Rep 21:463-80
20. Komai Y, Ushiki T (1991) The three-dimensional organization of collagen fbrils in the human cornea and sclera. Invest Ophthalmol Vis Sci 32:2244-58
21. Ueda A, Nishida T, Otori T, Fujita H (1987) Electron-microscopic studies on the presence of gap junctions between corneal fbroblasts in rabbits. Cell Tissue Res 249:473-5
22. Watsky MA (1995) Keratocyte gap junctional communication in normal and wounded rabbit corneas and human corneas. Invest Ophthalmol Vis Sci 36:2568-76
23. Michelacci YM (2003) Collagens and proteoglycans of the corneal extracellular matrix. Braz J Med Biol Res 36:1037-46
24. ten Tusscher MP, Klooster J, van der Want JJ, Lamers WP, Vrensen GF (1989) The allocation of nerve fbres to the anterior eye segment and peripheral ganglia of rats. I. The sensory innervation. Brain Res 494:95-104
25. Muller LJ, Pels L, Vrensen GF (1996) Ultrastructural organization of human corneal nerves. Invest Ophthalmol Vis Sci 37:476-88
26. Draize JH, Woodard G, Calvery HO (1944) Method for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther 82:377-89
27. Bagley DM, Waters D, Kong BM (1994) Development of a 10-day chorioallantoic membrane vascular assay as an alternative to the Draize rabbit eye irritation test. Food Chem Toxicol 32:1155-60
28. Gautheron P, Dukic M, Alix D, Sina JF (1992) Bovine corneal opacity and permeability test: an in vitro assay of ocular irritancy. Fundam Appl Toxicol 18:442-9
29. Ward SL, Walker TL, Dimitrijevich SD (1997) Evaluation of chemically-induced toxicity using an in vitro model of human corneal epithelium. Toxicol In Vitro 11
30. Klausner M, Hayden PJ, Breyfogle BA, Bellavance KL, Osborn MM, Cerven DR, et al (2003) The EpiOcular Prediction Model: A Reproducible In Vitro Means of Assessing Ocular Irritancy. In: Salem H, Katz SA, editors. Alternative toxicological methods Boca Raton, Fla.: CRC Press. p. 591
31. Zieske JD, Mason VS, Wasson ME, Meunier SF, Nolte CJ, Fukai N, et al. (1994) Basement membrane assembly and differentiation of cultured corneal cells: importance of culture environment and endothelial cell interaction. Exp Cell Res 214:621-33
32. Griffth M, Osborne R, Munger R, Xiong X, Doillon CJ, Laycock NL, et al. (1999) Functional human cor-neal equivalents constructed from cell lines. Science 286:2169-72
33. Suuronen EJ, Nakamura M, Watsky MA, Stys PK, Muller LJ, Munger R, et al. (2004) Innervated human corneal equivalents as in vitro models for nerve-target cell interactions. Faseb J 18:170-2
34. Chan K Y, Haschke RH (1982) Isolation and culture of corneal cells and their interactions with dissociated trigeminal neurons. Exp Eye Res 35:137-56
35. Riggott MJ, Moody SA (1987) Distribution of laminin and fbronectin along peripheral trigeminal axon pathways in the developing chick. J Comp Neurol 258:580-96
36. Corcoran J, Shroot B, Pizzey J, Maden M (2000) The role of retinoic acid receptors in neurite outgrowth from different populations of embryonic mouse dorsal root ganglia. J Cell Sci 113 (Pt 14):2567-74
37. Muller LJ, Vrensen GF, Pels L, Cardozo BN, Willekens B (1997) Architecture of human corneal nerves. Invest Ophthalmol Vis Sci 38:985-94
38. Brock JA, McLachlan EM, Belmonte C (1998) Tetrodo-toxin-resistant impulses in single nociceptor nerve terminals in guinea-pig cornea. J Physiol 512 (Pt 1):211-7
39. Nakamura M, Nishida T, Ofuji K, Reid TW, Mannis MJ, Murphy CJ (1997) Synergistic effect of substance P with epidermal growth factor on epithelial migration in rabbit cornea. Exp Eye Res 65:321-9
40. Trent JF, Kirsner RS (1998) Tissue engineered skin: Ap-ligraf, a bi-layered living skin equivalent. Int J Clin Pract 52:408-13
41. Suuronen EJ, McLaughlin CR, Stys PK, Nakamura M, Munger R, Griffth M (2004) Functional innervation in tissue engineered models for in vitro study and testing purposes. Toxicol Sci 82:525-33
42. Johansson S (1994) Graded action potentials generated by differentiated human neuroblastoma cells. Acta Phys-iol Scand 151:331-41
43. Araki-Sasaki K, Aizawa S, Hiramoto M, Nakamura M, Iwase O, Nakata K, et al. (2000) Substance P-induced cadherin expression and its signal transduction in a cloned human corneal epithelial cell line. J Cell Physiol 182:189-95
44. Suuronen EJ, Muzakare L, Doillon CJ, Kapila V, Li F, Ruel M, et al. (2006) Promotion of angiogenesis in tissue engineering: developing multicellular matrices with multiple capacities. Int J Artif Organs 29:1148-57
45. Bee JA (1982) The development and pattern of innervation of the avian cornea. Dev Biol 92:5-15
46. Adamis AP, Aiello LP, D'Amato RA (1999) Angiogen-esis and ophthalmic disease. Angiogenesis 3:9-14
47. Deroanne CF, Lapiere CM, Nusgens BV (2001) In vitro tubulogenesis of endothelial cells by relaxation of the coupling extracellular matrix-cytoskeleton. Cardiovasc Res 49:647-58
48. Sieminski AL, Hebbel RP, Gooch KJ (2005) Improved microvascular network in vitro by human blood outgrowth endothelial cells relative to vessel-derived en-dothelial cells. Tissue Eng 11:1332-45
49. Davis GE, Camarillo CW (1996) An alpha 2 beta 1 integrin-dependent pinocytic mechanism involving in-tracellular vacuole formation and coalescence regulates capillary lumen and tube formation in three-dimensional collagen matrix. Exp Cell Res 224:39-51
50. Korff T, Augustin HG (1999) Tensional forces in fbril-lar extracellular matrices control directional capillary sprouting. J Cell Sci 112 (Pt 19):3249-58
51. Yang S, Graham J, Kahn JW, Schwartz EA, Gerritsen ME (1999) Functional roles for PECAM-1 (CD31) and VE-cadherin (CD144) in tube assembly and lumen formation in three-dimensional collagen gels. Am J Pathol 155:887-95
52. Dietrich F, Lelkes PI (2006) Fine-tuning of a three-dimensional microcarrier-based angiogenesis assay for the analysis of endothelial- mesenchymal cell co-cultures in fbrin and collagen gels. Angiogenesis 9:111-25
53. Sieminski AL, Padera RF, Blunk T, Gooch KJ (2002) Systemic delivery of human growth hormone using genetically modifed tissue-engineered microvascular networks: prolonged delivery and endothelial survival with inclusion of nonendothelial cells. Tissue Eng 8:1057-69
54. Montesano R, Vassalli JD, Baird A, Guillemin R, Orci L (1986) Basic fbroblast growth factor induces angiogen-esis in vitro. Proc Natl Acad Sci U S A 83:7297-301
55. Satake S, Kuzuya M, Ramos MA, Kanda S, Iguchi A (1998) Angiogenic stimuli are essential for survival of vascular endothelial cells in three-dimensional collagen lattice. Biochem Biophys Res Commun 244:642-6
56. Madri JA, Pratt BM, Tucker AM (1988) Phenotypic modulation of endothelial cells by transforming growth factor-beta depends upon the composition and organization of the extracellular matrix. J Cell Biol 106:1375-84
57. Pepper MS, Ferrara N, Orci L, Montesano R (1992) Potent synergism between vascular endothelial growth factor and basic fbroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 189:824-31
58. Park HJ, Kong D, Iruela-Arispe L, Begley U, Tang D, Galper JB (2002) 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA. Circ Res 91:143-50
59. Takeda A, Hata Y, Shiose S, Sassa Y, Honda M, Fujisawa K, et al. (2003) Suppression of experimental choroidal neovascularization utilizing KDR selective receptor ty-rosine kinase inhibitor. Graefes Arch Clin Exp Ophthal-mol 241:765-72
60. Coussens LM, Werb Z (1996) Matrix metalloproteinases and the development of cancer. Chem Biol 3:895-904
61. Lafeur MA, Handsley MM, Knauper V, Murphy G, Edwards DR (2002) Endothelial tubulogenesis within f-brin gels specifcally requires the activity of membranetype-matrix metalloproteinases (MT-MMPs). J Cell Sci 115:3427-38
62. Chan VT, Zhang DN, Nagaravapu U, Hultquist K, Romero LI, Herron GS (1998) Membrane-type matrix metalloproteinases in human dermal microvascular en-dothelial cells: expression and morphogenetic correlation. J Invest Dermatol 111:1153-9
63. Overall CM, Kleifeld O (2006) Towards third generation matrix metalloproteinase inhibitors for cancer therapy. Br J Cancer 94:941-6
64. Thabet MM, Huizinga TW (2006) Drug evaluation: apratastat, a novel TACE/MMP inhibitor for rheumatoid arthritis. Curr Opin Investig Drugs 7:1014-9
65. Buckwalter JA, Mankin HJ (1998) Articular cartilage: tissue design and chondrocyte-matrix interactions. Instr Course Lect 47:477-86
66. Freemont AJ, Hoyland J (2006) Lineage plasticity and cell biology of fbrocartilage and hyaline cartilage: its signifcance in cartilage repair and replacement. Eur J Radiol 57:32-6
67. Hunziker EB (2002) Articular cartilage repair: basic science and clinical progress. A review of the current status and prospects. Osteoarthritis Cartilage 10:432-63
68. Marlovits S, Singer P, Zeller P, Mandl I, Haller J, Trattnig S (2006) Magnetic resonance observation of cartilage repair tissue (MOCART) for the evaluation of autologous chondrocyte transplantation: determination of interobserver variability and correlation to clinical outcome after 2 years. Eur J Radiol 57:16-23
69. Buckwalter JA, Mankin HJ (1998) Articular cartilage repair and transplantation. Arthritis Rheum 41:1331-42
70. Schultz O, Keyszer G, Zacher J, Sittinger M, Burmester GR (1997) Development of in vitro model systems for destructive joint diseases: novel strategies for establishing infammatory pannus. Arthritis Rheum 40:1420-8
71. Cortial D, Gouttenoire J, Rousseau CF, Ronziere MC, Piccardi N, Msika P, et al. (2006) Activation by IL-1 of bovine articular chondrocytes in culture within a 3D collagen-based scaffold. An in vitro model to address the effect of compounds with therapeutic potential in os-teoarthritis. Osteoarthritis Cartilage 14:631-40
72. Augustine AJ, Oleksyszyn J (1997) Glucocorticosteroids inhibit degradation in bovine cartilage explants stimulated with concomitant plasminogen and interleukin-1 alpha. Infamm Res 46:60-4
73. Cheung JO, Grant ME, Jones CJ, Hoyland JA, Freemont AJ, Hillarby MC (2003) Apoptosis of terminal hypertro-phic chondrocytes in an in vitro model of endochondral ossifcation. J Pathol 201:496-503
74. Slavin J (1996) The role of cytokines in wound healing. J Pathol 178:5-10
75. Smola H, Stark HJ, Thiekotter G, Mirancea N, Krieg T, Fusenig NE (1998) Dynamics of basement membrane formation by keratinocyte-fbroblast interactions in orga-notypic skin culture. Exp Cell Res 239:399-410
76. Werner S, Krieg T, Smola H (2007) Keratinocyte-fbro-blast interactions in wound healing. J Invest Dermatol 127:998-1008
77. Elias PM (2005) Stratum corneum defensive functions: an integrated view. J Invest Dermatol 125:183-200
78. Fuchs E (2007) Scratching the surface of skin development. Nature 445:834-42
79. McMillan JR, Akiyama M, Shimizu H (2003) Epidermal basement membrane zone components: ultrastructural distribution and molecular interactions. J Dermatol Sci 31:169-77
80. Kielty CM, Shuttleworth CA (1997) Microfbril-lar elements of the dermal matrix. Microsc Res Tech 38:413-27
81. Olsen BR (1991) Collagen Biosynthesis. In: Hay ED, editor. Cell Biology of the Extracellular Matrix. New York: Plenum Press. p. 177-220
82. Ushiki T (2002) Collagen fbers, reticular fbers and elastic fbers. A comprehensive understanding from a morphological viewpoint. Arch Histol Cytol 65:109-26
83. Bello YM, Falabella AF, Eaglstein WH (2001) Tissue-engineered skin. Current status in wound healing. Am J Clin Dermatol 2:305-13
84. Horch RE, Kopp J, Kneser U, Beier J, Bach AD (2005) Tissue engineering of cultured skin substitutes. J Cell Mol Med 9:592-608
85. Shakespeare PG (2005) The role of skin substitutes in the treatment of burn injuries. Clin Dermatol 23:413-8
86. Supp DM, Boyce ST (2005) Engineered skin substitutes: practices and potentials. Clin Dermatol 23:403-12
87. Boyce ST (1998) Skin substitutes from cultured cells and collagen-GAG polymers. Med Biol Eng Comput 36:791-800
88. Compton CC (1992) Current concepts in pediatric burn care: the biology of cultured epithelial autografts: an eight-year study in pediatric burn patients. Eur J Pediatr Surg 2:216-22
89. Eaglstein WH, Falanga V (1997) Tissue engineering and the development of Apligraf, a human skin equivalent. Clin Ther 19:894-905
90. Eaglstein WH, Falanga V (1998) Tissue engineering and the development of Apligraf, a human skin equivalent. Cutis 62:1-8
91. Eaglstein WH, Falanga V (1998) Tissue engineering and the development of Apligraf a human skin equivalent. Adv Wound Care 11:1-8
92. Hansbrough JF, Dore C, Hansbrough WB (1992) Clinical trials of a living dermal tissue replacement placed beneath meshed, split-thickness skin grafts on excised burn wounds. J Burn Care Rehabil 13:519-29
93. Higham MC, Dawson R, Szabo M, Short R, Haddow DB, MacNeil S (2003) Development of a stable chemically defned surface for the culture of human keratinocytes under serum-free conditions for clinical use. Tissue Eng 9:919-30
94. Kirsner RS (1998) The use of Apligraf in acute wounds. J Dermatol 25:805-11
95. Fentem JH, Botham PA (2002) ECVAM's activities in validating alternative tests for skin corrosion and irritation. Altern Lab Anim 30 Suppl 2:61-7
96. Osborne R, Perkins MA (1994) An approach for development of alternative test methods based on mechanisms of skin irritation. Food Chem Toxicol 32:133-42
97. Ponec M (2002) Skin constructs for replacement of skin tissues for in vitro testing. Adv Drug Deliv Rev 54 Suppl 1:S19-30
98. Welss T, Basketter DA, Schroder KR (2004) In vitro skin irritation: facts and future. State of the art review of mechanisms and models. Toxicol In Vitro 18:231-43
99. Bell E, Ivarsson B, Merrill C (1979) Production of a tissue-like structure by contraction of collagen lattices by human fbroblasts of different proliferative potential in vitro. Proc Natl Acad Sci U S A 76:1274-8
100. Boyce ST, Ham RG (1983) Calcium-regulated differentiation of normal human epidermal keratinocytes in chemically defned clonal culture and serum-free serial culture. J Invest Dermatol 81:33s-40s
101. Coulomb B, Lebreton C, Dubertret L (1989) Infuence of human dermal fbroblasts on epidermalization. J Invest Dermatol 92:122-5
102. Hennings H, Michael D, Cheng C, Steinert P, Holbrook K, Yuspa SH (1980) Calcium regulation of growth and differentiation of mouse epidermal cells in culture. Cell 19:245-54
103. Rheinwald JG, Green H (1975) Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 6:331-43
104. Wille JJ, Jr., Pittelkow MR, Shipley GD, Scott RE (1984) Integrated control of growth and differentiation of normal human prokeratinocytes cultured in serum-free medium: clonal analyses, growth kinetics, and cell cycle studies. J Cell Physiol 121:31-44
105. Yuspa SH, Kilkenny AE, Steinert PM, Roop DR (1989) Expression of murine epidermal differentiation markers is tightly regulated by restricted extracellular calcium concentrations in vitro. J Cell Biol 109:1207-17
106. Curren RD, Mun GC, Gibson DP, Aardema MJ (2006) Development of a method for assessing micronucleus induction in a 3D human skin model (EpiDerm). Mutat Res 607:192-204
107. Fentem JH (1999) Validation of in vitro Tests for Skin Corrosivity. Altex 16:150-3
108. Fentem JH, Briggs D, Chesne C, Elliott GR, Harbell JW, Heylings JR, et al. (2001) A prevalidation study on in vitro tests for acute skin irritation. results and evaluation by the Management Team. Toxicol In Vitro 15:57-93
109. Hoffmann S, Hartung T (2006) Designing validation studies more effciently according to the modular approach: retrospective analysis of the EPISKIN test for skin corrosion. Altern Lab Anim 34:177-91
110. Kandarova H, Liebsch M, Spielmann H, Genschow E, Schmidt E, Traue D, et al. (2006) Assessment of the human epidermis model SkinEthic RHE for in vitro skin corrosion testing of chemicals according to new OECD TG 431. Toxicol In Vitro 20:547-59
111. Netzlaff F, Lehr CM, Wertz PW, Schaefer UF (2005) The human epidermis models EpiSkin, SkinEthic and Epi-Derm: an evaluation of morphology and their suitability for testing phototoxicity, irritancy, corrosivity, and substance transport. Eur J Pharm Biopharm 60:167-78
112. Perkins MA, Osborne R, Johnson GR (1996) Development of an in vitro method for skin corrosion testing. Fundam Appl Toxicol 31:9-18
113. OECD (2004) OECD guideline for testing of chemicals. Paris, France: Organisation for Economic Co-operation and development;
114. Bell E, Ehrlich HP, Buttle DJ, Nakatsuji T (1981) Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness. Science 211:1052-4
115. El Ghalbzouri A, Jonkman MF, Dijkman R, Ponec M (2005) Basement membrane reconstruction in human skin equivalents is regulated by fbroblasts and/or ex-ogenously activated keratinocytes. J Invest Dermatol 124:79-86
116. Hansbrough JF, Morgan JL, Greenleaf GE, Bartel R (1993) Composite grafts of human keratinocytes grown on a polyglactin mesh-cultured fbroblast dermal substitute function as a bilayer skin replacement in full-thickness wounds on athymic mice. J Burn Care Rehabil 14:485-94
117. Hayden PJ, Ayehunie S, Jackson GR, Kupfer-Lamore S, Last TJ, Klausner M, et al (2003) In vitro skin equivalent models for toxicity testing. In: Salem H, Katz SA, editors. Alternative Toxicological Methods. Boca Raton, FL, USA: CRC Press. p. 229-47
118. Stark HJ, Szabowski A, Fusenig NE, Maas-Szabowski N (2004) Organotypic cocultures as skin equivalents: A complex and sophisticated in vitro system. Biol Proced Online 6:55-60
119. Funk WD, Wang CK, Shelton DN, Harley CB, Pagon GD, Hoeffer WK (2000) Telomerase expression restores dermal integrity to in vitro-aged fbroblasts in a reconstituted skin model. Exp Cell Res 258:270-8
120. Wang CK, Nelson CF, Brinkman AM, Miller AC, Hoef-fer WK (2000) Spontaneous cell sorting of fbroblasts and keratinocytes creates an organotypic human skin equivalent. J Invest Dermatol 114:674-80
121. Saarela J, Rehn M, Oikarinen A, Autio-Harmainen H, Pihlajaniemi T (1998) The short and long forms of type XVIII collagen show clear tissue specifcities in their expression and location in basement membrane zones in humans. Am J Pathol 153:611-26
122. Uchida Y, Hamanaka S (2006) Stratum corneum cer-amides: Function, origins and therepeutic applications. In: Elias PM, Feingold KR, editors. Skin Barrier. New York, NY, USA: Taylor & Francis. p. 43-64
123. Wertz PW. Biochemistry of human stratum corneum lip-ids. In: Elias PM, Feingold KR, editors. 2006 Skin Barrier. New York, N Y, USA: Taylor & Francis. p. 33-42.
124. Oestmann E, Lavrijsen AP, Hermans J, Ponec M (1993) Skin barrier function in healthy volunteers as assessed by transepidermal water loss and vascular response to hexyl nicotinate: intra-and inter-individual variability. Br J Dermatol 128:130-6
125. Pinnagoda J, Tupker RA, Agner T, Serup J (1990) Guidelines for transepidermal water loss (TEWL) measurement. A report from the Standardization Group of the European Society of Contact Dermatitis. Contact Dermatitis 22:164-78
126. Levy JJ, von Rosen J, Gassmuller J, Kleine Kuhlmann R, Lange L (1995) Validation of an in vivo wound healing model for the quantifcation of pharmacological effects on epidermal regeneration. Dermatology 190:136-41
127. Visscher M, Hoath SB, Conroy E, Wickett RR (2001) Effect of semipermeable membranes on skin barrier repair following tape stripping. Arch Dermatol Res 293:491-9
128. Breternitz M, Flach M, Prassler J, Elsner P, Fluhr JW (2007) Acute barrier disruption by adhesive tapes is in-fuenced by pressure, time and anatomical location: integrity and cohesion assessed by sequential tape stripping. A randomized, controlled study. Br J Dermatol 156:231-40
129. Wertz PW (2000) Lipids and barrier function of the skin. Acta Derm Venereol Suppl (Stockh) 208:7-11
130. Koria P, Brazeau D, Kirkwood K, Hayden P, Klausner M, Andreadis ST (2003) Gene expression profle of tissue engineered skin subjected to acute barrier disruption. J Invest Dermatol 121:368-82
131. Ponec M, Weerheim A, Kempenaar J, Mulder A, Goo-ris GS, Bouwstra J, et al. (1997) The formation of competent barrier lipids in reconstructed human epidermis requires the presence of vitamin C. J Invest Dermatol 109:348-55
132. Ponec M, Boelsma E, Weerheim A, Mulder A, Bouwstra J, Mommaas M (2000) Lipid and ultrastructural characterization of reconstructed skin models. Int J Pharm 203:211-25